title: Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant.
abstract: Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that cause loss of function of the CFTR channel on the apical surface of epithelial cells. The major CF-causing mutation, F508del-CFTR, is misfolded, retained in the endoplasmic reticulum, and degraded. Small molecule corrector compounds have been identified using high throughput screens, which partially rescue the trafficking defect of F508del-CFTR, allowing a fraction of the mutant protein to escape endoplasmic reticulum retention and traffic to the plasma membrane, where it exhibits partial function as a cAMP-regulated chloride channel. A subset of such corrector compounds binds directly to the mutant protein, prompting the hypothesis that they rescue the biosynthetic defect by inducing improved protein conformation. We tested this hypothesis directly by evaluating the consequences of a corrector compound on the conformation of each nucleotide binding domain (NBD) in the context of the full-length mutant protein in limited proteolytic digest studies. Interestingly, we found that VRT-325 was capable of partially restoring compactness in NBD1. However, VRT-325 had no detectable effect on the conformation of the second half of the molecule. In comparison, ablation of the di-arginine sequence, R(553)XR(555) (F508del-KXK-CFTR), modified protease susceptibility of NBD1, NBD2, and the full-length protein. Singly, each intervention led to a partial correction of the processing defect. Together, these interventions restored processing of F508del-CFTR to near wild type. Importantly, however, a defect in NBD1 conformation persisted, as did a defect in channel activation after the combined interventions. Importantly, this defect in channel activation can be fully corrected by the addition of the potentiator, VX-770.
authors: Programme in Molecular Structure and Function in the Research Institute, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
authors: Wilson
authors: W
authors: Yu
authors: Patrick
authors: P
authors: Kim Chiaw
authors: Christine E
authors: CE
authors: Bear
references: Trends Pharmacol Sci. 1999 Nov;20(11):448-53
references: 10542444
references: Mol Pharmacol. 2009 Jun;75(6):1430-8
references: 19339490
references: PLoS One. 2010 Nov 30;5(11):e15458
references: 21152102
references: FASEB J. 2009 Nov;23(11):3743-51
references: 19620404
references: Cell Mol Life Sci. 2008 Aug;65(16):2594-612
references: 18597042
references: J Biol Chem. 2010 Nov 12;285(46):35825-35
references: 20667826
references: J Mol Biol. 2010 Aug 13;401(2):194-210
references: 20561529
references: N Engl J Med. 2005 May 12;352(19):1992-2001
references: 15888700
references: J Mol Biol. 2010 Feb 19;396(2):406-30
references: 19944699
references: Mol Pharm. 2005 Sep-Oct;2(5):407-13
references: 16196493
references: N Engl J Med. 2010 Nov 18;363(21):1991-2003
references: 21083385
references: Biochem J. 2007 Sep 1;406(2):257-63
references: 17535157
references: Science. 1989 Sep 8;245(4922):1073-80
references: 2570460
references: Cell. 1993 Apr 23;73(2):335-46
references: 7682896
references: Science. 1989 Sep 8;245(4922):1066-73
references: 2475911
references: Cell Mol Life Sci. 2009 Nov;66(21):3469-86
references: 19707853
references: Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3256-61
references: 18305154
references: J Clin Invest. 2005 Sep;115(9):2564-71
references: 16127463
references: J Biol Chem. 2008 Sep 26;283(39):26383-90
references: 18658148
references: FEBS Lett. 2007 Mar 6;581(5):935-8
references: 17303126
references: Biochim Biophys Acta. 2006 May;1758(5):565-72
references: 16624253
references: Neuron. 1999 Mar;22(3):537-48
references: 10197533
references: Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18825-30
references: 19846789
references: Nature. 2006 Sep 14;443(7108):180-5
references: 16943773
references: Methods Enzymol. 1998;292:629-52
references: 9711588
references: J Biol Chem. 2007 Nov 16;282(46):33247-33251
references: 17911111
references: FASEB J. 2010 Aug;24(8):3103-12
references: 20233947
references: Nat Struct Mol Biol. 2005 Jan;12(1):17-25
references: 15619635
references: Mol Biol Cell. 2004 Jun;15(6):2684-96
references: 15075371
references: Proc Natl Acad Sci U S A. 2004 May 25;101(21):8221-6
references: 15141088
references: Mol Pharmacol. 2010 Sep;78(3):411-8
references: 20501743
references: J Biol Chem. 2001 Apr 20;276(16):12918-23
references: 11279083
references: Chem Biol. 2011 Feb 25;18(2):231-42
references: 21338920
references: Science. 2009 Mar 27;323(5922):1718-22
references: 19325113
references: Recept Channels. 1996;4(1):63-72
references: 8723647
references: Protein Sci. 2010 Oct;19(10):1932-47
references: 20687163
references: J Biol Chem. 2004 Sep 17;279(38):39620-7
references: 15272010
references: Protein Sci. 2010 Oct;19(10):1917-31
references: 20687133
references: Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1241-6
references: 19966305
references: Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19005-10
references: 18024585
references: Chem Biol. 2009 May 29;16(5):520-30
references: 19477416
references: Mol Biol Cell. 2010 Feb 15;21(4):597-609
references: 20032308
references: Am J Physiol Lung Cell Mol Physiol. 2006 Jun;290(6):L1117-30
references: 16443646
references: J Physiol. 2005 Dec 1;569(Pt 2):601-15
references: 16210354
references: Biochem J. 2008 Jul 1;413(1):29-36
references: 18361776
references: Mol Cell. 1999 Jul;4(1):137-42
references: 10445036